KK
CAPR icon

KLP Kapitalforvaltning’s Capricor Therapeutics CAPR Stock Holding History

KLP Kapitalforvaltning’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Hold
10,800
– – ﹤0.01% 1793
2026
Q1 		$328K Buy
+10,800
New +$288K ﹤0.01% 1618
2025
Q3 		– Sell
-10,900
Closed -$108K – 2181
2025
Q2 		$108K Buy
10,900
+4,300
+65% +$45.4K ﹤0.01% 2022
2025
Q1 		$62.6K Hold
6,600
– – ﹤0.01% 2160
2024
Q4 		$91.1K Buy
+6,600
New +$116K ﹤0.01% 2117

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KLP Kapitalforvaltning's CAPR Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 10,800 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

KLP Kapitalforvaltning first reported a position in CAPR in Q4 2024 and has held it in 5 quarters since. The position peaked at $328K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • KLP Kapitalforvaltning held 10,800 shares of Capricor Therapeutics worth $260K as of Q2 2026.
  • KLP Kapitalforvaltning left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1793 holding.
  • KLP Kapitalforvaltning first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • KLP Kapitalforvaltning's Capricor Therapeutics position peaked at $328K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.